Abstract
Liver toxicity has been one of the major causes for drug attrition. It has caused discontinuation of preclinical and clinical studies, and withdrawals and black box warnings of marketed drugs. Drug-induced hepatotoxicity may lead to organ failure and, ultimately, patient death. Understandably, liver toxicity is one of the most important issues in the drug development cycle. In silico models based on chemical structure provide a cost effective approach for hepatotoxicity, and it can help prioritize lab tests, preclinical and clinical studies. There is no doubt as to the need for predictive methods in every stage of the drug discovery pipeline. However there is a serious shortage of consistent data for the development of reliable models and developing genuinely predictive models for hepatotoxicity remains a challenge.
Current Computer-Aided Drug Design
Title: In Silico Prediction of Hepatotoxicity
Volume: 5 Issue: 2
Author(s): Ailan Cheng
Affiliation:
Abstract: Liver toxicity has been one of the major causes for drug attrition. It has caused discontinuation of preclinical and clinical studies, and withdrawals and black box warnings of marketed drugs. Drug-induced hepatotoxicity may lead to organ failure and, ultimately, patient death. Understandably, liver toxicity is one of the most important issues in the drug development cycle. In silico models based on chemical structure provide a cost effective approach for hepatotoxicity, and it can help prioritize lab tests, preclinical and clinical studies. There is no doubt as to the need for predictive methods in every stage of the drug discovery pipeline. However there is a serious shortage of consistent data for the development of reliable models and developing genuinely predictive models for hepatotoxicity remains a challenge.
Export Options
About this article
Cite this article as:
Cheng Ailan, In Silico Prediction of Hepatotoxicity, Current Computer-Aided Drug Design 2009; 5 (2) . https://dx.doi.org/10.2174/157340909788451883
DOI https://dx.doi.org/10.2174/157340909788451883 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Activated Protein C and Acute Kidney Injury: Selective Targeting of PAR-1
Current Drug Targets Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
Current Medicinal Chemistry How Should We Treat Hypertension and Dyslipidemia in Patients with Prediabetes?
Current Pharmaceutical Design Separating Fact from Fiction: Assessing the Potential of Modified Adenovirus Vectors for Use in Human Gene Therapy
Current Gene Therapy Cardiac Protection via Metabolic Modulation: An Emerging Role for Incretin-Based Therapies?
Cardiovascular & Hematological Agents in Medicinal Chemistry Adult Neurogenic and Antidepressant Effects of Adiponectin: A Potential Replacement for Exercise
CNS & Neurological Disorders - Drug Targets Advancement in Microsphere Preparation Using Natural Polymers and Recent Patents
Recent Patents on Drug Delivery & Formulation Relevance of Protein Isoforms in Proteomic Studies
Current Proteomics Pharmacological Inhibitors of Cysteinyl Leukotrienes Biosynthesis: Therapeutic Implications
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Allosteric Modulators of Class B G-Protein-Coupled Receptors
Current Neuropharmacology Gene Therapy to Improve High-Density Lipoprotein Metabolism and Function
Current Pharmaceutical Design The Update of NGAL in Acute Kidney Injury
Current Protein & Peptide Science Optimal Antibiotic Therapy in the Management of the Lung of the Critically Ill
Current Respiratory Medicine Reviews “Forbidden” Disulfides: Their Role as Redox Switches
Current Protein & Peptide Science Beyond Antibody-Mediated Rejection: Hyperacute Lung Rejection as a Paradigm for Dysregulated Inflammation
Current Drug Targets - Cardiovascular & Hematological Disorders Targeting Apelinergic System in Cardiometabolic Disease
Current Drug Targets The mTOR Pathway: A New Target in Cancer Therapy
Current Cancer Drug Targets Current Management of Neonatal Liver Tumors
Current Pediatric Reviews Improving Red Blood Cell K-Uptake and its Impact on O2/CO2 Exchange, and NO-Generation in Microvascular CHD: A Novel Therapeutic Approach
Recent Patents on Cardiovascular Drug Discovery Mechanism-Based Treatment in Chronic Neuropathic Pain: The Role of Antidepressants
Current Pharmaceutical Design